Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B
Version of Record online: 30 DEC 2003
Copyright © 2002 American Association for the Study of Liver Diseases
Volume 8, Issue 5, pages 433–439, May 2002
How to Cite
Fontana, R. J., Keeffe, E. B., Carey, W., Fried, M., Reddy, R., Kowdley, K. V., Soldevila-Pico, C., McClure, L. A. and Lok, A. S.F. (2002), Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl, 8: 433–439. doi: 10.1053/jlts.2002.32983
- Issue online: 30 DEC 2003
- Version of Record online: 30 DEC 2003
- National Institutes of Health. Grant Number: RO3-DK54595-01 (A.S.F.L.)
- 2Annual Report of the US Scientific Registry for Organ Sharing and the Organ Procurement and Transplantation Network—Transplant Data: 1988–1997. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, Table 22, 1998.
- 8Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort. Hepatology 2001; 34:411–416.MEDLINE, , , , .
- 16Determinants of survival in 133 patients with decompensated chronic hepatitis B treated with lamivudine [abstract]. Hepatology 2000;32;239A., , , , , , et al.